The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
The new center is one of only two in the Midwest the other is in Cleveland, Ohio and was the only developmental center funded this year. NIH has funded 20 such centers at major academic institutions across the country.
The center in Chicago involves investigators from Rush, the University of Illinois at Chicago (UIC) and Cook County Health and Hospitals System, who will collaborate across disciplines and institutions to advance HIV/AIDS research. Chicago ranks sixth among U.S. cities in the number of HIV cases, with approximately 21,000 known infections and another 5,000 presumed infections.
"With this grant, we have an unparalleled opportunity to make Chicago an epicenter for AIDS research, focusing on translational research that takes investigations from bench to bedside, and out to the community, to make a truly significant impact," said Alan Landay, PhD, chairman of immunology and microbiology at Rush, director of the new center, and an internationally recognized expert in immunology and HIV pathogenesis.
The NIH funding will be used to create shared "core" facilities that provide expertise and services to participating laboratories at all three institutions.
Rush will head the administrative and developmental cores, with responsibility for strategic planning and operational management. It will oversee scientific communications and funding for important new areas of research and launch a special outreach effort to share advances with the affected community in Chicago.
The University of Illinois at
|Contact: Sharon Butler|
Rush University Medical Center